The Board of Directors of Duopharma Biotech Berhad (hereinafter referred to as "Duopharma Biotech" or the "Company") wishes to announce that the Government has accepted the tender offer from Duopharma (M) Sendirian Berhad (hereinafter referred to as "DMSB") (a wholly-owned subsidiary of Duopharma Biotech) to supply the Products to the Ministry of Health's facilities (hereinafter referred to as the "Letter of Acceptance" or "LOA") upon the terms and conditions set out in the Letter of Award. DMSB has acknowledged acceptance of the LOA and submitted the same to the Ministry of Health on 9 June 2026. 

For full details of the announcement, please refer to the attached file.

This announcement is dated 9 June 2026.